0001181431-11-026542.txt : 20110503
0001181431-11-026542.hdr.sgml : 20110503
20110503130847
ACCESSION NUMBER: 0001181431-11-026542
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110430
FILED AS OF DATE: 20110503
DATE AS OF CHANGE: 20110503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CROWLEY Richard
CENTRAL INDEX KEY: 0001352961
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15313
FILM NUMBER: 11804116
MAIL ADDRESS:
STREET 1: IMCLONE SYSTEMS INCORPORATED
STREET 2: 180 VARICK STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
4
1
rrd310120.xml
CROWLEY FORM 4
X0303
4
2011-04-30
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001352961
CROWLEY Richard
SAVIENT PHARMACEUTICALS, INC.
ONE TOWER CENTER BLVD.
EAST BRUNSWICK
NJ
08816
0
1
0
0
EVP Biopharmaceutical Operatio
Common Stock, $.01 par value per share
2011-04-30
4
A
0
100000
11.62
D
100000
D
Option to Purchase Common Stock, $.01 par value
11.62
2011-04-30
4
A
0
50000
11.62
D
2012-04-30
2021-04-30
Common Stock, $.01 par value per share
50000
50000
D
The right to receive these shares is pursuant to a restricted stock grant that vests as follows: 25,000 on April 30, 2012, and 6,250 shares at the end of each successive three-month period until April 30, 2015, provided that the grantee remains employed by the Company on these dates.
These options will become exercisable as follows: 12,500 on April 30, 2012, and 3,125 shares at the end of each successive three-month period until April 30, 2015, provided the optionee remains employed by the Company on these dates.
/s/ Irina Azer Ishak for Richard Crowley
2011-05-03